Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
SoftOx Solutions AS ( (DE:6FV) ) has provided an update.
SoftOx Solutions AS has announced the election of Dr. Tore Duvold to its Board of Directors, bringing over 25 years of life science experience. His appointment is expected to enhance the company’s strategic growth and innovation efforts, particularly in addressing global health challenges related to infection and antimicrobial resistance.
More about SoftOx Solutions AS
SoftOx Solutions AS is a clinical-stage pharmaceutical company listed on Euronext Growth Oslo, focusing on developing pan-antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. The company’s technology is based on extensive research and development in collaboration with leading Nordic research institutes.
YTD Price Performance: 492.86%
Average Trading Volume: 40,478,555
Current Market Cap: NOK195.8M
Find detailed analytics on 6FV stock on TipRanks’ Stock Analysis page.